Dow Down0.22% Nasdaq Up0.14%

BioTime, Inc. (BTX)

-NYSE MKT
2.83 Down 0.02(0.70%) Aug 22, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 4,434   3,915   4,434  
Cost of Revenue793  434  79  
Gross Profit 3,642   3,481   4,355  
Operating Expenses
Research Development26,609  18,117  13,700  
Selling General and Administrative15,559  10,365  9,342  
Non Recurring17,459   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (55,985) (25,001) (18,686)
Income from Continuing Operations
Total Other Income/Expenses Net(204)(325)213  
Earnings Before Interest And Taxes(56,190)(25,306)(18,444)
Interest Expense -   -   -  
Income Before Tax(56,190)(25,306)(18,444)
Income Tax Expense(3,281) -   -  
Minority Interest9,026  3,880  1,928  
Net Income From Continuing Ops(43,883)(21,426)(16,516)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (43,883) (21,426) (16,516)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (43,883) (21,426) (16,516)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.